Clinical Trial Update: Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates the Phase 1/2 study of birinapant in combination with carboplatin for recurrent high-grade ovarian, fallopian tube, or primary p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Fallopian Tube Serous Carcinoma
• High-grade Ovarian Serous Carcinoma
• Peritoneal Serous Carcinoma

Drugs mentioned

• Birinapant
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma | Phase 1, Phase 2 | Status: WITHDRAWN